Assignee
PRECEDO PHARMACEUTICALS CO LTD
CN·6 granted patents·9 pending applications·0 citations·filing 2016–2022
Top patents by PatentIndex Score
15 records- 0158US12517114B2Primary gastrointestinal stromal tumor cell culture medium, culture method and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Granted Jan 6, 2026·0 cites·15 claims
- 0258US2024392251A1Culture medium and culture method for lung cancer epithelial cells, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0357US2025101378A1Culture medium and culture method for mammary epithelial cells, and use of mammary epithelial cellsPRECEDO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0457US2024344020A1Culture medium for lung cancer epithelial cells, culture method, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0556US2025129329A1Culture medium for hepatoma organoid culture, hepatoma organoid culture method, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0655US2024344035A1Culture Medium and Culture Method for Human Primary Acute Myeloid Leukemia CellsPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0754US12590951B2Culture medium and culture method for primary cells of intestinal cancerPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Granted Mar 31, 2026·0 cites·14 claims
- 0852US2023091960A1Culture medium for primary cells of esophageal squamous carcinoma, and cultivation method thereforPRECEDO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0952US2023235283A1Culture medium for esophageal squamous cell carcinoma epithelial cells, culture method, and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1052US2024418703A1Culture medium for primary ovarian cancer cells, culture method and application thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1147US10793543B2Selective C-KIT kinase inhibitorPRECEDO PHARMACEUTICALS CO LTD·Filed 2017·Granted Oct 6, 2020·0 cites·8 claims
- 1243US10781214B2Kinase inhibitor against wild-type and mutant EGFRPRECEDO PHARMACEUTICALS CO LTD·Filed 2016·Granted Sep 22, 2020·0 cites·11 claims
- 1343US2022389379A1Primary breast epithelial cell culture medium, culture method and use thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1436US10975082B2Inhibitor of FLT3 kinase and use thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2017·Granted Apr 13, 2021·0 cites·14 claims
- 1536US10350210B2EGFR and ALK dual inhibitorPRECEDO PHARMACEUTICALS CO LTD·Filed 2016·Granted Jul 16, 2019·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when PRECEDO PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →